FORM N-PX
ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED MANAGEMENT INVESTMENT COMPANY
INVESTMENT COMPANY ACT FILE NUMBER: 811-03010
EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER: Fidelity Advisor Series VII
Fund Name: Fidelity Advisor Biotechnology Fund
82 DEVONSHIRE STREET, BOSTON, MA 02109
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE)
ERIC D. ROITER, SECRETARY, 82 DEVONSHIRE STREET, BOSTON, MA 02109
(NAME AND ADDRESS OF AGENT FOR SERVICE)
REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE: 617-563-7000
DATE OF FISCAL YEAR END: JULY 31
DATE OF REPORTING PERIOD: 06/30/2006
SIGNATURES
PURSUANT TO THE REQUIREMENTS OF THE INVESTMENT COMPANY ACT OF 1940, THE REGISTRANT HAS DULY CAUSED THIS REPORT TO BE SIGNED ON ITS BEHALF BY THE UNDERSIGNED, THERE UNTO DULY AUTHORIZED.
Fidelity Advisor Series VII
BY: /s/ CHRISTINE REYNOLDS*
CHRISTINE REYNOLDS, PRESIDENT AND TREASURER
DATE: 08/08/2006 06:42:16 PM
*BY: /s/ CLAIRE S. WALPOLE
CLAIRE S. WALPOLE, VICE PRESIDENT, FIDELITY MANAGEMENT & RESEARCH COMPANY, PURSUANT TO A POWER OF ATTORNEY DATED JULY 31, 2006 AND FILED HEREWITH.
EXHIBIT A
VOTE SUMMARY REPORT
Fidelity Advisor Biotechnology Fund
07/01/2005 - 06/30/2006
Note: The Security ID will be the CUSIP (Committee on Uniform Securities Identification Procedures) when available. When CUSIP is not available, an alternate identifier, e.g., CINS, will be provided.
ISSUER NAME: ACADIA PHARMACEUTICALS INC. MEETING DATE: 06/13/2006 | ||||
TICKER: ACAD SECURITY ID: 004225108 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT ULI HACKSELL AS A DIRECTOR | Management | For | For |
1.2 | ELECT TORSTEN RASMUSSEN AS A DIRECTOR | Management | For | For |
1.3 | ELECT ALAN WALTON AS A DIRECTOR | Management | For | For |
2 | TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF OUR BOARD OF DIRECTORS OF PRICEWATERHOUSECOOPERS LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: ADAMS RESPIRATORY THERAPEUTICS, INC. MEETING DATE: 12/16/2005 | ||||
TICKER: ARXT SECURITY ID: 00635P107 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT DONALD J. LIEBENTRITT AS A DIRECTOR | Management | For | For |
1.2 | ELECT JOHN N. LILLY AS A DIRECTOR | Management | For | For |
1.3 | ELECT ANDREW N. SCHIFF, M.D. AS A DIRECTOR | Management | For | For |
2 | TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: ADOLOR CORPORATION MEETING DATE: 05/18/2006 | ||||
TICKER: ADLR SECURITY ID: 00724X102 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT DAVID M. MADDEN AS A DIRECTOR | Management | For | For |
1.2 | ELECT ROBERT T. NELSEN AS A DIRECTOR | Management | For | For |
2 | RATIFICATION OF KPMG LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | Management | For | For |
3 | AMENDMENTS TO THE ADOLOR CORPORATION 2003 STOCK-BASED INCENTIVE COMPENSATION PLAN | Management | For | Against |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: AFFYMETRIX, INC. MEETING DATE: 06/15/2006 | ||||
TICKER: AFFX SECURITY ID: 00826T108 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT STEPHEN P.A. FODOR, PHD AS A DIRECTOR | Management | For | For |
1.2 | ELECT PAUL BERG, PHD AS A DIRECTOR | Management | For | For |
1.3 | ELECT S.D. DESMOND-HELLMANN AS A DIRECTOR | Management | For | For |
1.4 | ELECT JOHN D. DIEKMAN, PHD AS A DIRECTOR | Management | For | For |
1.5 | ELECT VERNON R. LOUCKS, JR. AS A DIRECTOR | Management | For | For |
1.6 | ELECT DAVID B. SINGER AS A DIRECTOR | Management | For | For |
1.7 | ELECT ROBERT H. TRICE, PH.D. AS A DIRECTOR | Management | For | For |
1.8 | ELECT JOHN A. YOUNG AS A DIRECTOR | Management | For | For |
2 | TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: ALBANY MOLECULAR RESEARCH, INC. MEETING DATE: 06/01/2006 | ||||
TICKER: AMRI SECURITY ID: 012423109 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT PAUL S. ANDERSON, PH.D. AS A DIRECTOR | Management | For | For |
1.2 | ELECT DONALD E. KUHLA, PH.D. AS A DIRECTOR | Management | For | For |
1.3 | ELECT KEVIN O'CONNOR AS A DIRECTOR | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: ALEXION PHARMACEUTICALS, INC. MEETING DATE: 06/07/2006 | ||||
TICKER: ALXN SECURITY ID: 015351109 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT LEONARD BELL AS A DIRECTOR | Management | For | For |
1.2 | ELECT DAVID W. KEISER AS A DIRECTOR | Management | For | For |
1.3 | ELECT MAX LINK AS A DIRECTOR | Management | For | For |
1.4 | ELECT JOSEPH A. MADRI AS A DIRECTOR | Management | For | For |
1.5 | ELECT LARRY L. MATHIS AS A DIRECTOR | Management | For | For |
1.6 | ELECT R. DOUGLAS NORBY AS A DIRECTOR | Management | For | For |
1.7 | ELECT ALVIN S. PARVEN AS A DIRECTOR | Management | For | For |
1.8 | ELECT RUEDI E. WAEGER AS A DIRECTOR | Management | For | For |
2 | APPROVAL OF THE AMENDMENT TO 2004 INCENTIVE PLAN, AS DESCRIBED IN THE ACCOMPANYING PROXY STATEMENT, INCLUDING TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK AVAILABLE FOR ISSUANCE BY 775,000 SHARES (SUBJECT TO ADJUSTMENT IN THE EVENT OF STOCK SPLITS AND OTHER SIMILAR EVENTS). | Management | For | For |
3 | RATIFICATION OF APPOINTMENT BY THE BOARD OF DIRECTORS OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: ALKERMES, INC. MEETING DATE: 09/23/2005 | ||||
TICKER: ALKS SECURITY ID: 01642T108 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT FLOYD E. BLOOM AS A DIRECTOR | Management | For | For |
1.2 | ELECT ROBERT A. BREYER AS A DIRECTOR | Management | For | For |
1.3 | ELECT GERRI HENWOOD AS A DIRECTOR | Management | For | For |
1.4 | ELECT PAUL J. MITCHELL AS A DIRECTOR | Management | For | For |
1.5 | ELECT RICHARD F. POPS AS A DIRECTOR | Management | For | For |
1.6 | ELECT ALEXANDER RICH AS A DIRECTOR | Management | For | For |
1.7 | ELECT PAUL SCHIMMEL AS A DIRECTOR | Management | For | For |
1.8 | ELECT MARK B. SKALETSKY AS A DIRECTOR | Management | For | For |
1.9 | ELECT MICHAEL A. WALL AS A DIRECTOR | Management | For | For |
2 | TO APPROVE AN AMENDMENT TO THE 1999 STOCK OPTION PLAN TO INCREASE TO 19,900,000 THE NUMBER OF SHARES ISSUABLE UPON EXERCISE OF OPTIONS GRANTED THEREUNDER, AN INCREASE OF 3,000,000 SHARES. | Management | For | Against |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: ALNYLAM PHARMACEUTICALS, INC. MEETING DATE: 06/01/2006 | ||||
TICKER: ALNY SECURITY ID: 02043Q107 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT JOHN K. CLARKE AS A DIRECTOR | Management | For | Withhold |
1.2 | ELECT VICKI L. SATO, PH.D. AS A DIRECTOR | Management | For | Withhold |
1.3 | ELECT JAMES L. VINCENT AS A DIRECTOR | Management | For | Withhold |
2 | TO RATIFY THE APPOINTMENT BY THE BOARD OF DIRECTORS OF PRICEWATERHOUSECOOPERS LLP, AN INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM, AS THE COMPANY S INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: AMGEN INC. MEETING DATE: 05/10/2006 | ||||
TICKER: AMGN SECURITY ID: 031162100 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT MR. FREDERICK W. GLUCK AS A DIRECTOR | Management | For | For |
1.2 | ELECT ADM. J. PAUL REASON AS A DIRECTOR | Management | For | For |
1.3 | ELECT DR. DONALD B. RICE AS A DIRECTOR | Management | For | For |
1.4 | ELECT MR. LEONARD D SCHAEFFER AS A DIRECTOR | Management | For | For |
2 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS FOR THE YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
3 | STOCKHOLDER PROPOSAL #1 (STOCK RETENTION GUIDELINES). | Shareholder | Against | Against |
4 | STOCKHOLDER PROPOSAL #2 (EXECUTIVE COMPENSATION). | Shareholder | Against | Against |
5 | STOCKHOLDER PROPOSAL #3 (SHAREHOLDER RIGHTS PLANS). | Shareholder | Against | For |
6 | STOCKHOLDER PROPOSAL #4 (ANIMAL WELFARE POLICY). | Shareholder | Against | Against |
7 | STOCKHOLDER PROPOSAL #5 (MAJORITY ELECTIONS). | Shareholder | Against | Against |
8 | STOCKHOLDER PROPOSAL #6 (CORPORATE POLITICAL CONTRIBUTIONS). | Shareholder | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: AMYLIN PHARMACEUTICALS, INC. MEETING DATE: 05/17/2006 | ||||
TICKER: AMLN SECURITY ID: 032346108 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT STEVEN R. ALTMAN AS A DIRECTOR | Management | For | For |
1.2 | ELECT VAUGHN D. BRYSON AS A DIRECTOR | Management | For | For |
1.3 | ELECT JOSEPH C. COOK, JR. AS A DIRECTOR | Management | For | For |
1.4 | ELECT KARIN EASTHAM AS A DIRECTOR | Management | For | For |
1.5 | ELECT JAMES R. GAVIN III AS A DIRECTOR | Management | For | For |
1.6 | ELECT GINGER L. GRAHAM AS A DIRECTOR | Management | For | For |
1.7 | ELECT HOWARD E. GREENE, JR. AS A DIRECTOR | Management | For | For |
1.8 | ELECT JAY S. SKYLER AS A DIRECTOR | Management | For | For |
1.9 | ELECT JOSEPH P. SULLIVAN AS A DIRECTOR | Management | For | For |
1.10 | ELECT THOMAS R. TESTMAN AS A DIRECTOR | Management | For | For |
1.11 | ELECT JAMES N. WILSON AS A DIRECTOR | Management | For | For |
2 | TO APPROVE AN INCREASE OF 6,500,000 SHARES IN THE AGGREGATE NUMBER OF SHARES OF OUR COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER OUR 2001 EQUITY INCENTIVE PLAN. | Management | For | Against |
3 | TO APPROVE AN INCREASE OF 500,000 SHARES IN THE AGGREGATE NUMBER OF SHARES OF OUR COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER OUR 2001 EMPLOYEE STOCK PURCHASE PLAN. | Management | For | For |
4 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS INDEPENDENT AUDITORS OF THE COMPANY FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: ANADYS PHARMACEUTICALS, INC. MEETING DATE: 06/02/2006 | ||||
TICKER: ANDS SECURITY ID: 03252Q408 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT MARIOS FOTIADIS AS A DIRECTOR | Management | For | For |
2 | TO RATIFY APPOINTMENT OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: ARENA PHARMACEUTICALS, INC. MEETING DATE: 06/12/2006 | ||||
TICKER: ARNA SECURITY ID: 040047102 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT JACK LIEF AS A DIRECTOR | Management | For | For |
1.2 | ELECT DOMINIC P. BEHAN, PH.D. AS A DIRECTOR | Management | For | For |
1.3 | ELECT DONALD D. BELCHER AS A DIRECTOR | Management | For | For |
1.4 | ELECT SCOTT H. BICE AS A DIRECTOR | Management | For | For |
1.5 | ELECT H.F. HIXSON, JR., PH.D. AS A DIRECTOR | Management | For | For |
1.6 | ELECT J.C. LA FORCE, JR., PHD AS A DIRECTOR | Management | For | For |
1.7 | ELECT LOUIS J. LAVIGNE, JR. AS A DIRECTOR | Management | For | For |
1.8 | ELECT TINA S. NOVA, PH.D. AS A DIRECTOR | Management | For | For |
2 | APPROVAL OF THE ARENA PHARMACEUTICALS, INC., 2006 LONG-TERM INCENTIVE PLAN. | Management | For | For |
3 | APPROVAL OF THE 2001 ARENA EMPLOYEE STOCK PURCHASE PLAN, AS AMENDED. | Management | For | For |
4 | APPROVAL OF AN AMENDMENT TO ARENA S FIFTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE TOTAL NUMBER OF AUTHORIZED SHARES FROM 75,000,000 TO 150,000,000 AND THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK FROM 67,500,000 TO 142,500,000. | Management | For | For |
5 | RATIFICATION OF APPOINTMENT OF ERNST & YOUNG LLP AS INDEPENDENT AUDITORS. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: BARRIER THERAPEUTICS INC. MEETING DATE: 06/21/2006 | ||||
TICKER: BTRX SECURITY ID: 06850R108 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT CARL W. EHMANN, M.D. AS A DIRECTOR | Management | For | For |
1.2 | ELECT PETER ERNSTER AS A DIRECTOR | Management | For | For |
1.3 | ELECT CAROL RAPHAEL AS A DIRECTOR | Management | For | For |
2 | TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: BIOGEN IDEC INC. MEETING DATE: 05/25/2006 | ||||
TICKER: BIIB SECURITY ID: 09062X103 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT LAWRENCE C. BEST AS A DIRECTOR | Management | For | For |
1.2 | ELECT ALAN B. GLASSBERG AS A DIRECTOR | Management | For | For |
1.3 | ELECT ROBERT W. PANGIA AS A DIRECTOR | Management | For | For |
1.4 | ELECT WILLIAM D. YOUNG AS A DIRECTOR | Management | For | For |
2 | TO RATIFY THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
3 | TO APPROVE OUR 2006 NON-EMPLOYEE DIRECTORS EQUITY PLAN. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: BIOMARIN PHARMACEUTICAL INC. MEETING DATE: 06/21/2006 | ||||
TICKER: BMRN SECURITY ID: 09061G101 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT JEAN-JACQUES BIENAIME AS A DIRECTOR | Management | For | For |
1.2 | ELECT MICHAEL GREY AS A DIRECTOR | Management | For | For |
1.3 | ELECT ELAINE J. HERON AS A DIRECTOR | Management | For | For |
1.4 | ELECT JOSEPH KLEIN, III AS A DIRECTOR | Management | For | For |
1.5 | ELECT PIERRE LAPALME AS A DIRECTOR | Management | For | For |
1.6 | ELECT ALAN J. LEWIS AS A DIRECTOR | Management | For | For |
2 | PROPOSAL TO RATIFY THE SELECTION BY THE BOARD OF DIRECTORS OF KPMG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
3 | PROPOSAL TO APPROVE THE 2006 SHARE INCENTIVE PLAN FOR DIRECTORS AND EMPLOYEES. | Management | For | Against |
4 | PROPOSAL TO APPROVE THE AMENDED AND RESTATED 2006 EMPLOYEE STOCK PURCHASE PLAN. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: BRUKER BIOSCIENCES CORPORATION MEETING DATE: 06/29/2006 | ||||
TICKER: BRKR SECURITY ID: 116794108 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | TO CONSIDER AND ACT UPON A PROPOSAL TO APPROVE THE TRANSACTIONS CONTEMPLATED BY THE STOCK PURCHASE AGREEMENT, DATED AS OF APRIL 17, 2006, BY AND AMONG BRUKER BIOSCIENCES, BRUKEROPTICS INC. AND THE STOCKHOLDERS OF BRUKER OPTICS, INCLUDING THE ISSUANCE OF SHARES OF BRUKER BIOSCIENCES COMMON STOCK AS PART OF THE PURCHASE CONSIDERATION. | Management | For | For |
2 | TO AMEND THE BRUKER BIOSCIENCES CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE FROM 150,000,000 TO 200,000,000, CONTINGENT ON THE APPROVAL OF THE TRANSACTIONS CONTEMPLATED BY THE STOCK PURCHASE AGREEMENT AND RELATED ISSUANCE OF SHARES OF COMMON STOCK AS WELL AS THE CLOSING OF THE ACQUISITION. | Management | For | For |
3 | TO CONSIDER AND ACT UPON A PROPOSAL TO AMEND THE BRUKER BIOSCIENCES STOCK OPTION PLAN TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK FOR WHICH OPTIONS AND RESTRICTED STOCK MAY BE GRANTED UNDER THE STOCK OPTION PLAN FROM 6,320,000 TO 8,000,000. | Management | For | Against |
4.1 | ELECT RICHARD D. KNISS AS A DIRECTOR | Management | For | For |
4.2 | ELECT JORG C. LAUKIEN AS A DIRECTOR | Management | For | For |
4.3 | ELECT WILLIAM A. LINTON AS A DIRECTOR | Management | For | For |
5 | TO CONSIDER AND ACT UPON A PROPOSAL TO RATIFY, CONFIRM AND APPROVE THE SELECTION OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF BRUKER BIOSCIENCES FOR FISCAL 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: CARDIOME PHARMA CORP. MEETING DATE: 06/12/2006 | ||||
TICKER: CRME SECURITY ID: 14159U202 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT JACKIE M. CLEGG AS A DIRECTOR | Management | For | For |
1.2 | ELECT FRED MERMELSTEIN AS A DIRECTOR | Management | For | For |
1.3 | ELECT ROBERT W. RIEDER AS A DIRECTOR | Management | For | For |
1.4 | ELECT PETER W. ROBERTS AS A DIRECTOR | Management | For | For |
1.5 | ELECT MARK C. ROGERS AS A DIRECTOR | Management | For | For |
1.6 | ELECT HAROLD H. SHLEVIN AS A DIRECTOR | Management | For | For |
1.7 | ELECT RALPH SNYDERMAN AS A DIRECTOR | Management | For | For |
2 | TO APPOINT KPMG LLP, CHARTERED ACCOUNTANTS, AS AUDITORS FOR THE CORPORATION | Management | For | For |
3 | TO AUTHORIZE THE DIRECTORS TO FIX THE AUDITORS REMUNERATION | Management | For | For |
4 | TO PASS THE ORDINARY RESOLUTION, THE FULL TEXT OF WHICH IS SET OUT IN THE INFORMATION CIRCULAR, TO RATIFY, CONFIRM AND APPROVE AN AMENDMENT AND RELATED RESOLUTIONS RESPECTING THE CORPORATION S 2001 INCENTIVE STOCK OPTION PLAN. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: CELGENE CORPORATION MEETING DATE: 02/16/2006 | ||||
TICKER: CELG SECURITY ID: 151020104 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | PROPOSAL TO APPROVE AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO INCREASE THE TOTAL NUMBER OF SHARES OF STOCK WE ARE AUTHORIZED TO ISSUE FROM 280,000,000 TO 580,000,000 SHARES. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: CELGENE CORPORATION MEETING DATE: 06/14/2006 | ||||
TICKER: CELG SECURITY ID: 151020104 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT JOHN W. JACKSON AS A DIRECTOR | Management | For | For |
1.2 | ELECT SOL J. BARER, PH.D. AS A DIRECTOR | Management | For | For |
1.3 | ELECT ROBERT J. HUGIN AS A DIRECTOR | Management | For | For |
1.4 | ELECT JACK L. BOWMAN AS A DIRECTOR | Management | For | For |
1.5 | ELECT MICHAEL D. CASEY AS A DIRECTOR | Management | For | For |
1.6 | ELECT RODMAN L. DRAKE AS A DIRECTOR | Management | For | For |
1.7 | ELECT A. HULL HAYES, JR., MD AS A DIRECTOR | Management | For | For |
1.8 | ELECT GILLA KAPLAN, PH.D. AS A DIRECTOR | Management | For | For |
1.9 | ELECT RICHARD C.E. MORGAN AS A DIRECTOR | Management | For | For |
1.10 | ELECT WALTER L. ROBB, PH.D. AS A DIRECTOR | Management | For | For |
2 | AMEND THE 1998 STOCK INCENTIVE PLAN IN ORDER TO (I) INCREASE THE AGGREGATE NUMBER OF SHARES OF OUR COMMON STOCK FROM 62,000,000 TO 84,000,000, II) REMOVE THE LIMIT ON THE NUMBER OF SHARES OF OUR COMMON STOCK AND (III) PROVIDE THAT EACH SHARE OF OUR COMMON STOCK WILL BE COUNTED AS 1.6 SHARES AGAINST THE SHARE LIMIT, ALL AS MORE FULLY DESCRIBED IN THE PROXY STATEMENT. | Management | For | For |
3 | TO RATIFY THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: CEPHALON, INC. MEETING DATE: 05/17/2006 | ||||
TICKER: CEPH SECURITY ID: 156708109 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT FRANK BALDINO, JR., PHD AS A DIRECTOR | Management | For | For |
1.2 | ELECT WILLIAM P. EGAN AS A DIRECTOR | Management | For | For |
1.3 | ELECT MARTYN D. GREENACRE AS A DIRECTOR | Management | For | For |
1.4 | ELECT VAUGHN M. KAILIAN AS A DIRECTOR | Management | For | For |
1.5 | ELECT CHARLES A. SANDERS, M.D AS A DIRECTOR | Management | For | For |
1.6 | ELECT GAIL R. WILENSKY, PH.D. AS A DIRECTOR | Management | For | For |
1.7 | ELECT DENNIS L. WINGER AS A DIRECTOR | Management | For | For |
2 | APPROVAL OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION INCREASING THE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE | Management | For | Against |
3 | APPROVAL OF AMENDMENT TO THE 2004 EQUITY COMPENSATION PLAN TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE | Management | For | Against |
4 | RATIFICATION OF APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS FOR THE YEAR ENDING DECEMBER 31, 2006 | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: CHARLES RIVER LABORATORIES INTL., IN MEETING DATE: 05/09/2006 | ||||
TICKER: CRL SECURITY ID: 159864107 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT JAMES C. FOSTER AS A DIRECTOR | Management | For | For |
1.2 | ELECT STEPHEN D. CHUBB AS A DIRECTOR | Management | For | For |
1.3 | ELECT GEORGE E. MASSARO AS A DIRECTOR | Management | For | For |
1.4 | ELECT LINDA MCGOLDRICK AS A DIRECTOR | Management | For | For |
1.5 | ELECT GEORGE M. MILNE, JR. AS A DIRECTOR | Management | For | For |
1.6 | ELECT DOUGLAS E. ROGERS AS A DIRECTOR | Management | For | For |
1.7 | ELECT SAMUEL O. THIER AS A DIRECTOR | Management | For | For |
1.8 | ELECT WILLIAM H. WALTRIP AS A DIRECTOR | Management | For | For |
2 | PROPOSAL TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY S INDEPENDENT PUBLIC AUDITORS FOR THE FISCAL YEAR ENDING DECEMBER 30, 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: CHOLESTECH CORPORATION MEETING DATE: 08/17/2005 | ||||
TICKER: CTEC SECURITY ID: 170393102 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT MICHAEL D. CASEY AS A DIRECTOR | Management | For | For |
1.2 | ELECT JOHN L. CASTELLO AS A DIRECTOR | Management | For | For |
1.3 | ELECT ELIZABETH H. DAVILA AS A DIRECTOR | Management | For | For |
1.4 | ELECT STUART HEAP AS A DIRECTOR | Management | For | For |
1.5 | ELECT JOHN H. LANDON AS A DIRECTOR | Management | For | For |
1.6 | ELECT WARREN E. PINCKERT II AS A DIRECTOR | Management | For | For |
1.7 | ELECT LARRY Y. WILSON AS A DIRECTOR | Management | For | For |
2 | PROPOSAL TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING MARCH 31, 2006. | Management | For | For |
3 | PROPOSAL TO AMEND OUR 2000 STOCK INCENTIVE PROGRAM TO INCREASE THE AGGREGATE NUMBER OF SHARES OF COMMON STOCK RESERVED FOR ISSUANCE THEREUNDER BY 300,000 SHARES, AND TO APPROVE THE MATERIAL TERMS OF THE 2000 STOCK INCENTIVE PROGRAM FOR PURPOSES OF SECTION 162(M) OF THE INTERNAL REVENUE CODE. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: COLEY PHARMACEUTICAL GROUP INC. MEETING DATE: 06/21/2006 | ||||
TICKER: COLY SECURITY ID: 19388P106 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT R.L. BRATZLER, PH.D. AS A DIRECTOR | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: COMBINATORX INC MEETING DATE: 06/01/2006 | ||||
TICKER: CRXX SECURITY ID: 20010A103 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT ALEXIS BORISY AS A DIRECTOR | Management | For | For |
1.2 | ELECT PATRICK FORTUNE AS A DIRECTOR | Management | For | For |
2 | TO AMEND THE PROVISIONS OF THE COMPANY S 2004 INCENTIVE PLAN AS DESCRIBED IN THE ACCOMPANYING PROXY STATEMENT. | Management | For | Against |
3 | TO RATIFY THE APPOINTMENT BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF ERNST & YOUNG LLP, AN INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM, AS THE COMPANY S INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: CONNETICS CORPORATION MEETING DATE: 05/22/2006 | ||||
TICKER: CNCT SECURITY ID: 208192104 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT DAVID E. COHEN, M.D. AS A DIRECTOR | Management | For | For |
1.2 | ELECT R. ANDREW ECKERT AS A DIRECTOR | Management | For | For |
1.3 | ELECT CARL B. FELDBAUM AS A DIRECTOR | Management | For | For |
1.4 | ELECT DENISE M. GILBERT, PHD AS A DIRECTOR | Management | For | For |
1.5 | ELECT JOHN C. KANE AS A DIRECTOR | Management | For | For |
1.6 | ELECT THOMAS D. KILEY AS A DIRECTOR | Management | For | For |
1.7 | ELECT LEON E. PANETTA AS A DIRECTOR | Management | For | For |
1.8 | ELECT G. KIRK RAAB AS A DIRECTOR | Management | For | For |
1.9 | ELECT THOMAS G. WIGGANS AS A DIRECTOR | Management | For | For |
2 | TO APPROVE THE ADOPTION OF THE 2006 MANAGEMENT INCENTIVE PLAN. | Management | For | For |
3 | TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: COTHERIX, INC. MEETING DATE: 05/25/2006 | ||||
TICKER: CTRX SECURITY ID: 22163T103 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT JAMES I. HEALY MD, PHD AS A DIRECTOR | Management | For | For |
1.2 | ELECT HOWARD B. ROSEN AS A DIRECTOR | Management | For | For |
1.3 | ELECT DONALD J. SANTEL AS A DIRECTOR | Management | For | For |
2 | APPROVAL OF AN AMENDMENT AND RESTATEMENT OF THE COTHERIX, INC. 2004 EQUITY INCENTIVE PLAN TO INCREASE THE NUMBER OF SHARES AVAILABLE UNDER THE PLAN BY 2,000,000 SHARES, REVISE THE AUTOMATIC SHARE INCREASE PROVISION AND APPROVE CERTAIN SHARE LIMITS. | Management | For | Against |
3 | TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT PUBLIC ACCOUNTANTS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: CRITICAL THERAPEUTICS, INC. MEETING DATE: 04/25/2006 | ||||
TICKER: CRTX SECURITY ID: 22674T105 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT RICHARD W. DUGAN AS A DIRECTOR | Management | For | For |
1.2 | ELECT CHRISTOPHER MIRABELLI AS A DIRECTOR | Management | For | For |
1.3 | ELECT JAMES B. TANANBAUM, AS A DIRECTOR | Management | For | For |
2 | TO APPROVE THE ADOPTION OF THE COMPANY S 2006 EMPLOYEE STOCK PURCHASE PLAN, UNDER WHICH 400,000 SHARES OF COMMON STOCK WILL BE AUTHORIZED FOR ISSUANCE. | Management | For | Against |
3 | TO RATIFY THE SELECTION BY THE BOARD OF DIRECTORS OF DELOITTE & TOUCHE LLP AS THE COMPANY S REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: CUBIST PHARMACEUTICALS, INC. MEETING DATE: 06/08/2006 | ||||
TICKER: CBST SECURITY ID: 229678107 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT DAVID W. MARTIN, JR. AS A DIRECTOR | Management | For | For |
1.2 | ELECT KENNETH M. BATE AS A DIRECTOR | Management | For | For |
2 | RATIFY THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS OUR INDEPENDENT AUDITOR FOR THE FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
3 | RATIFY, ADOPT AND APPROVE THE AMENDED AND RESTATED 2002 DIRECTORS EQUITY INCENTIVE PLAN. | Management | For | Against |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: CV THERAPEUTICS, INC. MEETING DATE: 06/06/2006 | ||||
TICKER: CVTX SECURITY ID: 126667104 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT LOUIS G. LANGE AS A DIRECTOR | Management | For | For |
1.2 | ELECT PETER BARTON HUTT AS A DIRECTOR | Management | For | For |
1.3 | ELECT THOMAS E. SHENK AS A DIRECTOR | Management | For | For |
2 | TO APPROVE THE AMENDMENT AND RESTATEMENT OF THE COMPANY S EMPLOYEE STOCK PURCHASE PLAN. | Management | For | Against |
3 | TO APPROVE THE AMENDMENT AND RESTATEMENT OF THE COMPANY S AMENDED AND RESTATED CERTIFICATE OF INCORPORATION IN ORDER TO (I) INCREASE THE COMPANY S AUTHORIZED NUMBER OF SHARES OF COMMON STOCK FROM 85,000,000 SHARES TO 180,000,000 SHARES AND (II) AMEND THE LIABILITY AND INDEMNIFICATION PROVISIONS WITH RESPECT TO THE COMPANY S DIRECTORS AND OFFICERS. | Management | For | Against |
4 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: CYBERONICS, INC. MEETING DATE: 09/28/2005 | ||||
TICKER: CYBX SECURITY ID: 23251P102 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT ROBERT P. CUMMINS AS A DIRECTOR | Management | For | For |
1.2 | ELECT STANLEY H. APPEL, M.D. AS A DIRECTOR | Management | For | For |
1.3 | ELECT TONY COELHO AS A DIRECTOR | Management | For | For |
1.4 | ELECT GUY C. JACKSON AS A DIRECTOR | Management | For | For |
1.5 | ELECT ALAN J. OLSEN AS A DIRECTOR | Management | For | For |
1.6 | ELECT MICHAEL J. STRAUSS, MD AS A DIRECTOR | Management | For | For |
1.7 | ELECT REESE S. TERRY, JR. AS A DIRECTOR | Management | For | For |
2 | PROPOSAL TO RATIFY THE APPOINTMENT OF REGISTERED KPMG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE 2006 FISCAL YEAR. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: CYPRESS BIOSCIENCE, INC. MEETING DATE: 06/12/2006 | ||||
TICKER: CYPB SECURITY ID: 232674507 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT JAY D. KRANZLER AS A DIRECTOR | Management | For | For |
1.2 | ELECT PERRY MOLINOFF AS A DIRECTOR | Management | For | For |
1.3 | ELECT DANIEL H. PETREE AS A DIRECTOR | Management | For | For |
2 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP BY THE AUDIT COMMITTEE OF THE COMPANY S BOARD OF DIRECTORS AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: DENDREON CORPORATION MEETING DATE: 06/07/2006 | ||||
TICKER: DNDN SECURITY ID: 24823Q107 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT SUSAN B. BAYH AS A DIRECTOR | Management | For | For |
1.2 | ELECT M. BLAKE INGLE, PH.D. AS A DIRECTOR | Management | For | For |
1.3 | ELECT DAVID L. URDAL, PH.D. AS A DIRECTOR | Management | For | For |
2 | APPROVAL OF THE RATIFICATION OF THE SELECTION OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: DOV PHARMACEUTICAL, INC. MEETING DATE: 05/22/2006 | ||||
TICKER: DOVP SECURITY ID: 259858108 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT DANIEL S. VAN RIPER AS A DIRECTOR | Management | For | For |
1.2 | ELECT DENNIS G. PODLESAK AS A DIRECTOR | Management | For | For |
2 | TO APPROVE AN AMENDMENT TO THE COMPANY S 2000 STOCK OPTION AND GRANT PLAN TO INCREASE THE TOTAL NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THE PLAN BY 1,000,000 TO 4,692,090 FROM 3,692,090 | Management | For | Against |
3 | TO RATIFY THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2006 | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: ELAN CORPORATION, PLC MEETING DATE: 05/25/2006 | ||||
TICKER: ELN SECURITY ID: 284131208 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | RECEIVE THE FINANCIAL STATEMENTS TOGETHER WITH THE REPORTS OF THE DIRECTORS AND AUDITORS THEREON. | Management | For | For |
2.1 | ELECT MR. LAURENCE CROWLEY AS A DIRECTOR | Management | For | For |
2.2 | ELECT MR. WILLIAM DANIEL AS A DIRECTOR | Management | For | For |
2.3 | ELECT MR. KELLY MARTIN AS A DIRECTOR | Management | For | For |
2.4 | ELECT DR. GORAN ANDO AS A DIRECTOR | Management | For | For |
2.5 | ELECT MR. SHANE COOKE AS A DIRECTOR | Management | For | For |
2.6 | ELECT DR. LARS EKMAN AS A DIRECTOR | Management | For | For |
2.7 | ELECT MR. GARY KENNEDY AS A DIRECTOR | Management | For | For |
2.8 | ELECT MS. NANCY LURKER AS A DIRECTOR | Management | For | For |
3 | AUTHORISE THE DIRECTORS TO FIX THE REMUNERATION OF THE AUDITORS. | Management | For | For |
4 | APPROVE THE ELAN CORPORATION, PLC 2006 LONG TERM INCENTIVE PLAN. | Management | For | Against |
5 | APPROVE THE AMENDMENT TO THE EMPLOYEE EQUITY PURCHASE PLAN. | Management | For | For |
6 | AUTHORISE THE DIRECTORS TO ISSUE SECURITIES. | Management | For | For |
7 | TO AUTHORISE THE DISAPPLICATION OF PRE-EMPTION RIGHTS ON THE ALLOTMENT OF UP TO 40 MILLION SHARES FOR CASH. | Management | For | For |
8 | TO REPLACE ARTICLES 58 AND 59 OF THE ARTICLES OF ASSOCIATION. | Management | For | For |
9 | TO REPLACE ARTICLE 62 OF THE ARTICLES OF ASSOCIATION. | Management | For | For |
10 | TO AUTHORISE THE COMPANY TO MAKE MARKET PURCHASES OF OWN SHARES. | Management | For | For |
11 | TO SET THE RE-ISSUE PRICE RANGE FOR TREASURY SHARES. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: ENZO BIOCHEM, INC. MEETING DATE: 01/19/2006 | ||||
TICKER: ENZ SECURITY ID: 294100102 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT ELAZAR RABBANI, PH.D AS A DIRECTOR | Management | For | For |
1.2 | ELECT JOHN B. SIAS AS A DIRECTOR | Management | For | For |
1.3 | ELECT MARCUS A. CONANT, M.D AS A DIRECTOR | Management | For | For |
2 | TO RATIFY AND APPROVE THE AMENDMENT AND RESTATEMENT OF THE COMPANY S 2005 EQUITY COMPENSATION INCENTIVE PLAN AMONG OTHER THINGS, ALL AS MORE FULLY DESCRIBED IN THE PROXY STATEMENT. | Management | For | Against |
3 | TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE COMPANY S FISCAL YEAR ENDING JULY 31, 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: ENZON PHARMACEUTICALS, INC. MEETING DATE: 05/18/2006 | ||||
TICKER: ENZN SECURITY ID: 293904108 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT PHILLIP M. RENFRO AS A DIRECTOR | Management | For | For |
2 | APPROVAL OF THE AMENDMENT OF THE 2001 INCENTIVE STOCK PLAN TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK ISSUABLE THEREUNDER BY AN ADDITIONAL 4,000,000 SHARES. | Management | For | Against |
3 | TO APPROVE THE AMENDMENT AND RESTATEMENT OF OUR RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK FROM 90,000,000 SHARES TO 170,000,000 SHARES. | Management | For | Against |
4 | RATIFICATION OF THE SELECTION OF KPMG LLP TO AUDIT THE CONSOLIDATED FINANCIAL STATEMENTS OF THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: EXELIXIS, INC. MEETING DATE: 05/01/2006 | ||||
TICKER: EXEL SECURITY ID: 30161Q104 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT CHARLES COHEN, PH.D. AS A DIRECTOR | Management | For | For |
1.2 | ELECT GEORGE POSTE, DVM, PHD AS A DIRECTOR | Management | For | For |
1.3 | ELECT JACK WYSZOMIERSKI AS A DIRECTOR | Management | For | For |
2 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: FIDELITY CASH CENTRAL FUND MEETING DATE: 02/15/2006 | ||||
TICKER: -- SECURITY ID: 31635A105 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT DENNIS J. DIRKS AS A DIRECTOR | Management | For | For |
1.2 | ELECT ALBERT R. GAMPER, JR. AS A DIRECTOR | Management | For | For |
1.3 | ELECT ROBERT M. GATES AS A DIRECTOR | Management | For | For |
1.4 | ELECT GEORGE H. HEILMEIER AS A DIRECTOR | Management | For | For |
1.5 | ELECT EDWARD C. JOHNSON 3D AS A DIRECTOR | Management | For | For |
1.6 | ELECT STEPHEN P. JONAS AS A DIRECTOR | Management | For | For |
1.7 | ELECT MARIE L. KNOWLES AS A DIRECTOR | Management | For | For |
1.8 | ELECT NED C. LAUTENBACH AS A DIRECTOR | Management | For | For |
1.9 | ELECT WILLIAM O. MCCOY AS A DIRECTOR | Management | For | For |
1.10 | ELECT ROBERT L. REYNOLDS AS A DIRECTOR | Management | For | For |
1.11 | ELECT CORNELIA M. SMALL AS A DIRECTOR | Management | For | For |
1.12 | ELECT WILLIAM S. STAVROPOULOS AS A DIRECTOR | Management | For | For |
1.13 | ELECT KENNETH L. WOLFE AS A DIRECTOR | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: GEN-PROBE INCORPORATED MEETING DATE: 05/17/2006 | ||||
TICKER: GPRO SECURITY ID: 36866T103 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT JOHN W. BROWN AS A DIRECTOR | Management | For | For |
1.2 | ELECT HENRY L. NORDHOFF AS A DIRECTOR | Management | For | For |
2 | TO APPROVE AN AMENDMENT TO THE 2003 INCENTIVE AWARD PLAN OF THE COMPANY TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE BY 3,000,000 SHARES. | Management | For | For |
3 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: GENENTECH, INC. MEETING DATE: 04/20/2006 | ||||
TICKER: DNA SECURITY ID: 368710406 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT HERBERT W. BOYER AS A DIRECTOR | Management | For | For |
1.2 | ELECT WILLIAM M. BURNS AS A DIRECTOR | Management | For | For |
1.3 | ELECT ERICH HUNZIKER AS A DIRECTOR | Management | For | For |
1.4 | ELECT JONATHAN K.C. KNOWLES AS A DIRECTOR | Management | For | For |
1.5 | ELECT ARTHUR D. LEVINSON AS A DIRECTOR | Management | For | For |
1.6 | ELECT DEBRA L. REED AS A DIRECTOR | Management | For | For |
1.7 | ELECT CHARLES A. SANDERS AS A DIRECTOR | Management | For | For |
2 | TO APPROVE AN AMENDMENT TO THE 1991 EMPLOYEE STOCK PLAN. | Management | For | For |
3 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF GENENTECH FOR THE YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: GENOMIC HEALTH, INC. MEETING DATE: 05/24/2006 | ||||
TICKER: GHDX SECURITY ID: 37244C101 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT RANDAL W. SCOTT AS A DIRECTOR | Management | For | For |
1.2 | ELECT KIMBERLY J. POPOVITS AS A DIRECTOR | Management | For | For |
1.3 | ELECT JULIAN C. BAKER AS A DIRECTOR | Management | For | For |
1.4 | ELECT BROOK H. BYERS AS A DIRECTOR | Management | For | For |
1.5 | ELECT FRED E. COHEN AS A DIRECTOR | Management | For | For |
1.6 | ELECT SAMUEL D. COLELLA AS A DIRECTOR | Management | For | For |
1.7 | ELECT MICHAEL D. GOLDBERG AS A DIRECTOR | Management | For | For |
1.8 | ELECT RANDALL S. LIVINGSTON AS A DIRECTOR | Management | For | For |
1.9 | ELECT WOODROW A. MYERS AS A DIRECTOR | Management | For | For |
2 | TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS GENOMIC HEALTH S INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS FOR THE 2006 FISCAL YEAR. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: GENZYME CORPORATION MEETING DATE: 05/25/2006 | ||||
TICKER: GENZ SECURITY ID: 372917104 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT DR. VICTOR DZAU AS A DIRECTOR | Management | For | For |
1.2 | ELECT SENATOR CONNIE MACK AS A DIRECTOR | Management | For | For |
1.3 | ELECT HENRI A. TERMEER AS A DIRECTOR | Management | For | For |
2 | A PROPOSAL TO AMEND THE 2004 EQUITY INCENTIVE PLAN TO PROVIDE FOR THE GRANT OF RESTRICTED STOCK AND RESTRICTED STOCK UNITS AND INCREASE THE NUMBER OF SHARES OF COMMON STOCK COVERED BY THE PLAN BY 7,000,000 SHARES. | Management | For | Against |
3 | A PROPOSAL TO AMEND THE 1998 DIRECTOR STOCK OPTION PLAN TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK COVERED BY THE PLAN BY 300,000 SHARES. | Management | For | Against |
4 | THE AMENDMENT AND RESTATEMENT OF OUR RESTATED ARTICLES OF ORGANIZATION TO DECLASSIFY OUR BOARD SO THAT, BEGINNING IN 2007, ALL DIRECTORS ARE ELECTED FOR ONE-YEAR TERMS. | Management | For | For |
5 | A PROPOSAL TO RATIFY THE SELECTION OF INDEPENDENT AUDITORS FOR 2006. | Management | For | For |
6 | A SHAREHOLDER PROPOSAL THAT EXECUTIVE SEVERANCE ARRANGEMENTS BE APPROVED BY SHAREHOLDERS. | Shareholder | Against | Against |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: GILEAD SCIENCES, INC. MEETING DATE: 05/10/2006 | ||||
TICKER: GILD SECURITY ID: 375558103 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT PAUL BERG AS A DIRECTOR | Management | For | For |
1.2 | ELECT JOHN F. COGAN AS A DIRECTOR | Management | For | For |
1.3 | ELECT ETIENNE F. DAVIGNON AS A DIRECTOR | Management | For | For |
1.4 | ELECT JAMES M. DENNY AS A DIRECTOR | Management | For | For |
1.5 | ELECT JOHN W. MADIGAN AS A DIRECTOR | Management | For | For |
1.6 | ELECT JOHN C. MARTIN AS A DIRECTOR | Management | For | For |
1.7 | ELECT GORDON E. MOORE AS A DIRECTOR | Management | For | For |
1.8 | ELECT NICHOLAS G. MOORE AS A DIRECTOR | Management | For | For |
1.9 | ELECT GAYLE E. WILSON AS A DIRECTOR | Management | For | For |
2 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF GILEAD FOR THE FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
3 | TO APPROVE AN AMENDMENT TO GILEAD S 2004 EQUITY INCENTIVE PLAN. | Management | For | For |
4 | TO APPROVE GILEAD S CODE SECTION 162(M) BONUS PLAN AND CERTAIN PERFORMANCE-BASED PROVISIONS THEREUNDER. | Management | For | For |
5 | TO APPROVE AN AMENDMENT TO GILEAD S RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE AUTHORIZED NUMBER OF SHARES OF GILEAD S COMMON STOCK FROM 700,000,000 TO 1,400,000,000 SHARES. | Management | For | For |
6 | TO APPROVE A STOCKHOLDER PROPOSAL REQUESTING A REPORT ON THE HIV/AIDS, TUBERCULOSIS AND MALARIA PANDEMIC. | Shareholder | Against | Against |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: GUILFORD PHARMACEUTICALS INC. MEETING DATE: 09/29/2005 | ||||
TICKER: GLFD SECURITY ID: 401829106 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | TO ADOPT THE AGREEMENT AND PLAN OF MERGER BY AND AMONG GUILFORD PHARMACEUTICALS INC., MGI PHARMA, INC. AND GRANITE ACQUISITION, INC., DATED JULY 20, 2005, PURSUANT TO WHICH GRANITE ACQUISITION, INC. WILL MERGE WITH AND INTO GUILFORD AND GUILFORD WILL BECOME A WHOLLY OWNED SUBSIDIARY OF MGI PHARMA, INC. | Management | For | For |
2 | TO AUTHORIZE THE PROXIES TO VOTE TO ADJOURN THE SPECIAL MEETING OF STOCKHOLDERS, IN THEIR SOLE DISCRETION, FOR THE PURPOSE OF SOLICITING ADDITIONAL VOTES FOR PROPOSAL 1. | Management | For | Abstain |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: HARVARD BIOSCIENCE, INC. MEETING DATE: 05/18/2006 | ||||
TICKER: HBIO SECURITY ID: 416906105 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT CHANE GRAZIANO AS A DIRECTOR | Management | For | For |
1.2 | ELECT EARL R. LEWIS AS A DIRECTOR | Management | For | For |
1.3 | ELECT GEORGE UVEGES AS A DIRECTOR | Management | For | For |
2 | TO APPROVE AN AMENDMENT TO THE HARVARD BIOSCIENCE, INC. AMENDED AND RESTATED 2000 STOCK OPTION AND INCENTIVE PLAN TO INCREASE THE NUMBER OF SHARES AVAILABLE FOR ISSUANCE THEREUNDER BY 2,000,000. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: HUMAN GENOME SCIENCES, INC. MEETING DATE: 04/26/2006 | ||||
TICKER: HGSI SECURITY ID: 444903108 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT H. THOMAS WATKINS AS A DIRECTOR | Management | For | For |
1.2 | ELECT AUGUSTINE LAWLOR AS A DIRECTOR | Management | For | For |
1.3 | ELECT WILLIAM D. YOUNG AS A DIRECTOR | Management | For | For |
2 | TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: IDEXX LABORATORIES, INC. MEETING DATE: 05/10/2006 | ||||
TICKER: IDXX SECURITY ID: 45168D104 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT WILLIAM T. END AS A DIRECTOR | Management | For | For |
1.2 | ELECT BARRY C. JOHNSON, PHD AS A DIRECTOR | Management | For | For |
1.3 | ELECT BRIAN P. MCKEON AS A DIRECTOR | Management | For | For |
2 | TO APPROVE AN AMENDMENT TO THE COMPANY S RESTATED CERTIFICATE OF INCORPORATION INCREASING THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK FROM 60,000,000 TO 120,000,000. | Management | For | For |
3 | RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE CURRENT FISCAL YEAR. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: IMMUNOGEN, INC. MEETING DATE: 11/08/2005 | ||||
TICKER: IMGN SECURITY ID: 45253H101 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT MITCHEL SAYARE, PH.D. AS A DIRECTOR | Management | For | For |
1.2 | ELECT WALTER A BLATTLER, PH.D AS A DIRECTOR | Management | For | For |
1.3 | ELECT DAVID W. CARTER AS A DIRECTOR | Management | For | For |
1.4 | ELECT STUART F. FEINER AS A DIRECTOR | Management | For | For |
1.5 | ELECT MARK SKALETSKY AS A DIRECTOR | Management | For | For |
1.6 | ELECT J.J. VILLAFRANCA, PH.D. AS A DIRECTOR | Management | For | For |
1.7 | ELECT NICOLE ONETTO, MD AS A DIRECTOR | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: IMMUNOMEDICS, INC. MEETING DATE: 08/19/2005 | ||||
TICKER: IMMU SECURITY ID: 452907108 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | TO APPROVE AN AMENDMENT TO THE COMPANY S CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK FROM 70 MILLION TO 110 MILLION SHARES. | Management | For | For |
2 | TO APPROVE THE ISSUANCE OF SHARES OF COMMON STOCK UPON CONVERSION INTO COMMON STOCK OF THE 2008 NOTES AND EXERCISE OF THE WARRANTS ISSUED BY THE COMPANY ON APRIL 29, 2005. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: IMMUNOMEDICS, INC. MEETING DATE: 12/07/2005 | ||||
TICKER: IMMU SECURITY ID: 452907108 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT DAVID M. GOLDENBERG AS A DIRECTOR | Management | For | For |
1.2 | ELECT CYNTHIA L. SULLIVAN AS A DIRECTOR | Management | For | For |
1.3 | ELECT MORTON COLEMAN AS A DIRECTOR | Management | For | For |
1.4 | ELECT MARVIN E. JAFFE AS A DIRECTOR | Management | For | For |
1.5 | ELECT BRIAN A. MARKISON AS A DIRECTOR | Management | For | For |
1.6 | ELECT MARY E. PAETZOLD AS A DIRECTOR | Management | For | For |
1.7 | ELECT RICHARD R. PIVIROTTO AS A DIRECTOR | Management | For | For |
1.8 | ELECT DON C. STARK AS A DIRECTOR | Management | For | For |
2 | PROPOSAL TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING JUNE 30, 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: INCYTE CORPORATION MEETING DATE: 05/23/2006 | ||||
TICKER: INCY SECURITY ID: 45337C102 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT RICHARD U. DE SCHUTTER AS A DIRECTOR | Management | For | For |
1.2 | ELECT BARRY M. ARIKO AS A DIRECTOR | Management | For | For |
1.3 | ELECT JULIAN C. BAKER AS A DIRECTOR | Management | For | For |
1.4 | ELECT PAUL A. BROOKE AS A DIRECTOR | Management | For | For |
1.5 | ELECT MATTHEW W. EMMENS AS A DIRECTOR | Management | For | For |
1.6 | ELECT PAUL A. FRIEDMAN AS A DIRECTOR | Management | For | For |
1.7 | ELECT JOHN F. NIBLACK AS A DIRECTOR | Management | For | For |
1.8 | ELECT ROY A. WHITFIELD AS A DIRECTOR | Management | For | For |
2 | TO AMEND THE COMPANY S 1997 EMPLOYEE STOCK PURCHASE PLAN TO INCREASE THE NUMBER OF SHARES AVAILABLE FOR ISSUANCE THEREUNDER FROM 3,100,000 SHARES TO 3,850,000 SHARES. | Management | For | For |
3 | TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: INHIBITEX, INC. MEETING DATE: 05/18/2006 | ||||
TICKER: INHX SECURITY ID: 45719T103 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT CARL E. BROOKS AS A DIRECTOR | Management | For | For |
1.2 | ELECT ROBERT A. HAMM AS A DIRECTOR | Management | For | For |
1.3 | ELECT LOUIS W. SULLIVAN AS A DIRECTOR | Management | For | For |
2 | RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR INHIBITEX, INC. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: INTRALASE CORP. MEETING DATE: 07/21/2005 | ||||
TICKER: ILSE SECURITY ID: 461169104 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT THOMAS S. PORTER AS A DIRECTOR | Management | For | For |
1.2 | ELECT JAY T. HOLMES AS A DIRECTOR | Management | For | For |
2 | TO RATIFY THE SELECTION OF DELOITTE & TOUCHE, LLP AS INDEPENDENT AUDITORS OF THE COMPANY FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2005. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: INTRALASE CORP. MEETING DATE: 05/23/2006 | ||||
TICKER: ILSE SECURITY ID: 461169104 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT WILLIAM J. LINK AS A DIRECTOR | Management | For | For |
1.2 | ELECT GILBERT H. KLIMAN AS A DIRECTOR | Management | For | For |
2 | TO APPROVE AMENDMENTS TO THE COMPANY S 2004 STOCK INCENTIVE PLAN. | Management | For | Against |
3 | TO INCREASE BY TWO MILLION SHARES THE NUMBER OF SHARES AVAILABLE FOR ISSUANCE UNDER THE COMPANY S 2004 STOCK INCENTIVE PLAN. | Management | For | Against |
4 | TO RATIFY THE SELECTION OF DELOITTE & TOUCHE, LLP AS THE COMPANY S INDEPENDENT AUDITORS FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: INVITROGEN CORPORATION MEETING DATE: 04/21/2006 | ||||
TICKER: IVGN SECURITY ID: 46185R100 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT GREGORY T. LUCIER AS A DIRECTOR | Management | For | For |
1.2 | ELECT DONALD W. GRIMM AS A DIRECTOR | Management | For | For |
2 | RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG AS INDEPENDENT AUDITORS OF THE COMPANY FOR FISCAL YEAR 2006 | Management | For | For |
3 | AMENDMENT OF THE COMPANY S 1998 EMPLOYEE STOCK PURCHASE PLAN | Management | For | For |
4 | AMENDMENT OF THE COMPANY S RESTATED CERTIFICATE OF INCORPORATION | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: ISIS PHARMACEUTICALS, INC. MEETING DATE: 05/03/2006 | ||||
TICKER: ISIS SECURITY ID: 464330109 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT RICHARD D. DIMARCHI * AS A DIRECTOR | Management | For | For |
1.2 | ELECT CHRIS F.O. GABRIELI * AS A DIRECTOR | Management | For | For |
1.3 | ELECT JOSEPH KLEIN, III ** AS A DIRECTOR | Management | For | For |
1.4 | ELECT FREDERICK T. MUTO * AS A DIRECTOR | Management | For | For |
2 | TO APPROVE AN AMENDMENT TO THE ISIS RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE AUTHORIZED NUMBER OF SHARES OF COMMON STOCK FROM 100,000,000 TO 200,000,000 SHARES. | Management | For | For |
3 | TO APPROVE AN AMENDMENT TO THE 2002 NON-EMPLOYEE DIRECTORS STOCK OPTION PLAN TO (I) INCREASE THE TOTAL NUMBER OF SHARES RESERVED FOR ISSUANCE UNDER THE DIRECTORS PLAN FROM 600,000 SHARES TO 850,000 SHARES, AND (II) INCREASE THE ANNUAL NON-DISCRETIONARY STOCK OPTION GRANT FOR ISIS NON-EMPLOYEE DIRECTORS FROM 10,000 SHARE TO 12,500 SHARES. | Management | For | Against |
4 | TO RATIFY THE AUDIT COMMITTEE S SELECTION OF ERNST & YOUNG LLP AS INDEPENDENT AUDITORS FOR OUR 2006 FISCAL YEAR. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: IVAX CORPORATION MEETING DATE: 10/27/2005 | ||||
TICKER: IVX SECURITY ID: 465823102 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | PROPOSAL TO APPROVE THE AGREEMENT AND PLAN OF MERGER, DATED AS OF JULY 25, 2005, BY AND AMONG IVAX CORPORATION, TEVA PHARMACEUTICALS INDUSTRIES LIMITED, IVORY ACQUISITION SUB, INC. AND IVORY ACQUISITION SUB II, INC. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: KOS PHARMACEUTICALS, INC. MEETING DATE: 04/27/2006 | ||||
TICKER: KOSP SECURITY ID: 500648100 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT MICHAEL JAHARIS AS A DIRECTOR | Management | For | For |
1.2 | ELECT DANIEL M. BELL AS A DIRECTOR | Management | For | For |
1.3 | ELECT ROBERT E. BALDINI AS A DIRECTOR | Management | For | For |
1.4 | ELECT ADRIAN ADAMS AS A DIRECTOR | Management | For | For |
1.5 | ELECT JOHN BRADEMAS, PH.D. AS A DIRECTOR | Management | For | For |
1.6 | ELECT KEVIN T. FERRO AS A DIRECTOR | Management | For | For |
1.7 | ELECT STEVEN JAHARIS, MD AS A DIRECTOR | Management | For | For |
1.8 | ELECT NICOLAOS E. MADIAS, MD AS A DIRECTOR | Management | For | For |
1.9 | ELECT MARK NOVITCH, MD AS A DIRECTOR | Management | For | For |
1.10 | ELECT WILLIAM D. PRUITT AS A DIRECTOR | Management | For | For |
1.11 | ELECT FREDERICK B. WHITTEMORE AS A DIRECTOR | Management | For | For |
2 | AMEND AND RESTATE THE KOS PHARMACEUTICALS, INC. 1996 STOCK OPTION PLAN (I) TO INCREASE THE NUMBER OF SHARES OF THE COMPANY S COMMON STOCK FROM 17,000,000 TO 22,000,000; (II) TO PROVIDE FOR THE GRANTING OF RESTRICTED STOCK; (III) TO EXTEND THE TERMINATION DATE; AND (IV) TO MAKE CERTAIN OTHER MINOR AMENDMENTS TO THE PLAN BASED ON RECENT CHANGES IN THE LAW. | Management | For | Against |
3 | RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: LIGAND PHARMACEUTICALS INCORPORATED MEETING DATE: 01/31/2006 | ||||
TICKER: LGND SECURITY ID: 53220K207 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT HENRY F. BLISSENBACH AS A DIRECTOR | Management | For | For |
1.2 | ELECT ALEXANDER D. CROSS AS A DIRECTOR | Management | For | For |
1.3 | ELECT JOHN GROOM AS A DIRECTOR | Management | For | For |
1.4 | ELECT IRVING S. JOHNSON AS A DIRECTOR | Management | For | For |
1.5 | ELECT JOHN W. KOZARICH AS A DIRECTOR | Management | For | For |
1.6 | ELECT DANIEL S. LOEB AS A DIRECTOR | Management | For | For |
1.7 | ELECT CARL C. PECK AS A DIRECTOR | Management | For | For |
1.8 | ELECT JEFFREY R. PERRY AS A DIRECTOR | Management | For | For |
1.9 | ELECT BRIGETTE ROBERTS AS A DIRECTOR | Management | For | For |
1.10 | ELECT DAVID E. ROBINSON AS A DIRECTOR | Management | For | For |
1.11 | ELECT MICHAEL A. ROCCA AS A DIRECTOR | Management | For | For |
2 | AMENDMENT OF 2002 STOCK INCENTIVE PLAN | Management | For | Against |
3 | APPOINTMENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: LUMINEX CORPORATION MEETING DATE: 05/25/2006 | ||||
TICKER: LMNX SECURITY ID: 55027E102 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT PATRICK J. BALTHROP AS A DIRECTOR | Management | For | For |
1.2 | ELECT G. WALTER LOEWENBAUM II AS A DIRECTOR | Management | For | For |
1.3 | ELECT J. STARK THOMPSON AS A DIRECTOR | Management | For | For |
1.4 | ELECT KEVIN M. MCNAMARA AS A DIRECTOR | Management | For | For |
2 | PROPOSAL TO APPROVE THE COMPANY S 2006 EQUITY INCENTIVE PLAN. | Management | For | Against |
3 | PROPOSAL TO APPROVE THE COMPANY S 2006 MANAGEMENT STOCK PURCHASE PLAN. | Management | For | Against |
4 | PROPOSAL TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR FISCAL 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: MANNKIND CORPORATION MEETING DATE: 05/25/2006 | ||||
TICKER: MNKD SECURITY ID: 56400P201 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT ALFRED E. MANN AS A DIRECTOR | Management | For | For |
1.2 | ELECT HAKAN S. EDSTROM AS A DIRECTOR | Management | For | For |
1.3 | ELECT KATHLEEN CONNELL, PH.D. AS A DIRECTOR | Management | For | For |
1.4 | ELECT RONALD CONSIGLIO AS A DIRECTOR | Management | For | For |
1.5 | ELECT MICHAEL A. FRIEDMAN, MD AS A DIRECTOR | Management | For | For |
1.6 | ELECT LLEW KELTNER, MD. PH.D. AS A DIRECTOR | Management | For | For |
1.7 | ELECT KENT KRESA AS A DIRECTOR | Management | For | For |
1.8 | ELECT DAVID H. MACCALLUM AS A DIRECTOR | Management | For | For |
1.9 | ELECT HENRY L. NORDHOFF AS A DIRECTOR | Management | For | For |
2 | APPROVAL OF 4 MILLION SHARE INCREASE TO 2004 EQUITY INCENTIVE PLAN RESERVE FOR FUTURE ISSUANCE | Management | For | Against |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: MARTEK BIOSCIENCES CORPORATION MEETING DATE: 03/16/2006 | ||||
TICKER: MATK SECURITY ID: 572901106 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT JAMES R. BEERY AS A DIRECTOR | Management | For | Withhold |
1.2 | ELECT ROBERT J. FLANAGAN AS A DIRECTOR | Management | For | Withhold |
2 | TO APPROVE A PROPOSED AMENDMENT OF THE 2004 STOCK INCENTIVE PLAN, INCLUDING AN INCREASE IN THE NUMBER OF SHARES ISSUABLE UNDER THE PLAN | Management | For | Against |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: MEDAREX, INC. MEETING DATE: 05/18/2006 | ||||
TICKER: MEDX SECURITY ID: 583916101 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT DR. DONALD L. DRAKEMAN AS A DIRECTOR | Management | For | For |
1.2 | ELECT DR. RONALD J. SALDARINI AS A DIRECTOR | Management | For | For |
1.3 | ELECT MR. CHARLES R. SCHALLER AS A DIRECTOR | Management | For | For |
2 | THE APPROVAL OF AN AMENDMENT TO MEDAREX S 2005 EQUITY INCENTIVE PLAN TO INCREASE THE AGGREGATE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THE PLAN BY 5,500,000 SHARES. | Management | For | For |
3 | THE RATIFICATION OF THE SELECTION BY THE BOARD OF ERNST & YOUNG LLP AS MEDAREX S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: MEDIMMUNE, INC. MEETING DATE: 05/25/2006 | ||||
TICKER: MEDI SECURITY ID: 584699102 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT WAYNE T. HOCKMEYER AS A DIRECTOR | Management | For | For |
1.2 | ELECT DAVID M. MOTT AS A DIRECTOR | Management | For | For |
1.3 | ELECT DAVID BALTIMORE AS A DIRECTOR | Management | For | For |
1.4 | ELECT M. JAMES BARRETT AS A DIRECTOR | Management | For | For |
1.5 | ELECT JAMES H. CAVANAUGH AS A DIRECTOR | Management | For | For |
1.6 | ELECT BARBARA H. FRANKLIN AS A DIRECTOR | Management | For | For |
1.7 | ELECT GORDON S. MACKLIN AS A DIRECTOR | Management | For | For |
1.8 | ELECT GEORGE M. MILNE, JR. AS A DIRECTOR | Management | For | For |
1.9 | ELECT ELIZABETH H.S. WYATT AS A DIRECTOR | Management | For | For |
2 | TO APPROVE AN AMENDMENT TO THE 2003 NON-EMPLOYEE DIRECTORS STOCK OPTION PLAN. | Management | For | Against |
3 | TO APPROVE AND RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: MGI PHARMA, INC. MEETING DATE: 05/09/2006 | ||||
TICKER: MOGN SECURITY ID: 552880106 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT ANDREW J. FERRARA AS A DIRECTOR | Management | For | For |
1.2 | ELECT EDWARD W. MEHRER AS A DIRECTOR | Management | For | For |
1.3 | ELECT HUGH E. MILLER AS A DIRECTOR | Management | For | For |
1.4 | ELECT DEAN J. MITCHELL AS A DIRECTOR | Management | For | For |
1.5 | ELECT LEON O. MOULDER, JR. AS A DIRECTOR | Management | For | For |
1.6 | ELECT DAVID B. SHARROCK AS A DIRECTOR | Management | For | For |
1.7 | ELECT WANETA C. TUTTLE, PH.D. AS A DIRECTOR | Management | For | For |
1.8 | ELECT ARTHUR L. WEAVER, M.D. AS A DIRECTOR | Management | For | For |
2 | TO APPROVE THE AMENDED AND RESTATED 1997 STOCK INCENTIVE PLAN (THE INCENTIVE PLAN ) TO, AMONG OTHER THINGS, INCREASE THE NUMBER OF SHARES AVAILABLE FOR ISSUANCE UNDER THE INCENTIVE PLAN BY 7,400,000 SHARES. | Management | For | Against |
3 | TO RATIFY THE APPOINTMENT OF KPMG LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: MILLENNIUM PHARMACEUTICALS, INC. MEETING DATE: 05/04/2006 | ||||
TICKER: MLNM SECURITY ID: 599902103 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT DEBORAH DUNSIRE AS A DIRECTOR | Management | For | For |
1.2 | ELECT ROBERT F. FRIEL AS A DIRECTOR | Management | For | For |
1.3 | ELECT NORMAN C. SELBY AS A DIRECTOR | Management | For | For |
2 | APPROVE AN AMENDMENT TO OUR 1996 EMPLOYEE STOCK PURCHASE PLAN THAT RESERVES AN ADDITIONAL 2,000,000 SHARES OF MILLENNIUM COMMON STOCK FOR ISSUANCE UNDER THE PLAN TO EMPLOYEES. | Management | For | For |
3 | RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: MOMENTA PHARMACEUTICALS, INC. MEETING DATE: 06/15/2006 | ||||
TICKER: MNTA SECURITY ID: 60877T100 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT JOHN K. CLARKE AS A DIRECTOR | Management | For | Withhold |
1.2 | ELECT ROBERT S. LANGER, JR. AS A DIRECTOR | Management | For | Withhold |
1.3 | ELECT STEPHEN T. REEDERS AS A DIRECTOR | Management | For | Withhold |
2 | TO RATIFY THE SELECTION BY THE BOARD OF DIRECTORS OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: MYOGEN, INC. MEETING DATE: 05/04/2006 | ||||
TICKER: MYOG SECURITY ID: 62856E104 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT M.R. BRISTOW, MD, PH.D AS A DIRECTOR | Management | For | For |
1.2 | ELECT KIRK K. CALHOUN AS A DIRECTOR | Management | For | For |
1.3 | ELECT J. WILLIAM FREYTAG, PHD AS A DIRECTOR | Management | For | For |
1.4 | ELECT JUDITH A. HEMBERGER PHD AS A DIRECTOR | Management | For | For |
1.5 | ELECT JERRY T. JACKSON AS A DIRECTOR | Management | For | For |
1.6 | ELECT DANIEL J. MITCHELL AS A DIRECTOR | Management | For | For |
1.7 | ELECT ARNOLD L. ORONSKY, PH.D AS A DIRECTOR | Management | For | For |
1.8 | ELECT MICHAEL J. VALENTINO AS A DIRECTOR | Management | For | For |
2 | TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF ERNST & YOUNG LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: MYRIAD GENETICS, INC. MEETING DATE: 01/06/2006 | ||||
TICKER: MYGN SECURITY ID: 62855J104 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | PROPOSAL TO AMEND THE 2003 EMPLOYEE, DIRECTOR AND CONSULTANT STOCK OPTION PLAN TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK AVAILABLE FOR ISSUANCE THEREUNDER BY 1,200,000 SHARES. | Management | For | Against |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: NEKTAR THERAPEUTICS MEETING DATE: 06/01/2006 | ||||
TICKER: NKTR SECURITY ID: 640268108 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT ROBERT B. CHESS AS A DIRECTOR | Management | For | For |
1.2 | ELECT SUSAN WANG AS A DIRECTOR | Management | For | For |
1.3 | ELECT ROY A. WHITFIELD AS A DIRECTOR | Management | For | For |
2 | TO APPROVE AN AMENDMENT TO OUR 2000 EQUITY INCENTIVE PLAN TO INCREASE THE AGGREGATE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THE PLAN BY 7,000,000 SHARES. | Management | For | Against |
3 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF NEKTAR THERAPEUTICS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: NEUROCHEM INC. MEETING DATE: 05/09/2006 | ||||
TICKER: NRMX SECURITY ID: 64125K101 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | THE ELECTION AS DIRECTORS OF THOSE PERSONS SET FORTH IN THE ACCOMPANYING PROXY CIRCULAR AS MANAGEMENT S NOMINEES. | Management | For | For |
2 | APPOINTMENT OF KPMG LLP, CHARTERED ACCOUNTANTS, AS AUDITORS OF THE COMPANY FOR THE ENSUING YEAR AND AUTHORIZING THE AUDIT COMMITTEE TO FIX THEIR REMUNERATION. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: NEUROCRINE BIOSCIENCES, INC. MEETING DATE: 06/30/2006 | ||||
TICKER: NBIX SECURITY ID: 64125C109 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT JOSEPH A. MOLLICA, PHD AS A DIRECTOR | Management | For | For |
1.2 | ELECT WYLIE W. VALE, PH.D. AS A DIRECTOR | Management | For | For |
1.3 | ELECT W. THOMAS MITCHELL AS A DIRECTOR | Management | For | For |
2 | TO APPROVE AN AMENDMENT TO THE COMPANY S CERTIFICATE OF INCORPORATION, AS AMENDED, TO INCREASE THE AUTHORIZED NUMBER OF SHARES OF COMMON STOCK FROM 50,000,000 SHARES TO 110,000,000 SHARES. | Management | For | For |
3 | TO APPROVE AN AMENDMENT TO THE COMPANY S 2003 INCENTIVE STOCK PLAN, AS AMENDED, TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK RESERVED FOR ISSUANCE FROM 3,300,000 TO 4,300,000 SHARES. | Management | For | Against |
4 | TO APPROVE THE AMENDED AND RESTATED EMPLOYEE STOCK PURCHASE PLAN, WHICH, AS AMENDED AND RESTATED, INCREASES THE NUMBER OF SHARES OF COMMON STOCK RESERVED FOR ISSUANCE FROM 625,000 TO 725,000 SHARES. | Management | For | For |
5 | TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: NEW RIVER PHARMACEUTICALS INC. MEETING DATE: 05/04/2006 | ||||
TICKER: NRPH SECURITY ID: 648468205 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT CESAR L. ALVAREZ AS A DIRECTOR | Management | For | For |
1.2 | ELECT DAVID S. BARLOW AS A DIRECTOR | Management | For | For |
1.3 | ELECT LARRY D. HORNER AS A DIRECTOR | Management | For | For |
1.4 | ELECT RANDAL J. KIRK AS A DIRECTOR | Management | For | For |
1.5 | ELECT KRISH S. KRISHNAN AS A DIRECTOR | Management | For | For |
1.6 | ELECT BURTON E. SOBEL, M.D. AS A DIRECTOR | Management | For | For |
2 | THE PROPOSAL TO RATIFY THE APPOINTMENT BY OUR AUDIT COMMITTEE OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: NITROMED, INC. MEETING DATE: 05/17/2006 | ||||
TICKER: NTMD SECURITY ID: 654798503 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT ARGERIS KARABELAS PH.D. AS A DIRECTOR | Management | For | For |
1.2 | ELECT ROBERT S. COHEN AS A DIRECTOR | Management | For | For |
1.3 | ELECT FRANK L. DOUGLAS MD PHD AS A DIRECTOR | Management | For | For |
1.4 | ELECT ZOLA HOROVITZ, PH.D. AS A DIRECTOR | Management | For | For |
1.5 | ELECT MARK LESCHLY AS A DIRECTOR | Management | For | For |
1.6 | ELECT JOHN W. LITTLECHILD AS A DIRECTOR | Management | For | For |
1.7 | ELECT JOSEPH LOSCALZO, MD PHD AS A DIRECTOR | Management | For | For |
1.8 | ELECT DAVEY S. SCOON AS A DIRECTOR | Management | For | For |
2 | TO ADOPT THE AMENDMENT TO THE COMPANY S 2003 EMPLOYEE STOCK PURCHASE PLAN. | Management | For | For |
3 | TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: OSI PHARMACEUTICALS, INC. MEETING DATE: 06/14/2006 | ||||
TICKER: OSIP SECURITY ID: 671040103 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT ROBERT A. INGRAM AS A DIRECTOR | Management | For | For |
1.2 | ELECT COLIN GODDARD, PH.D. AS A DIRECTOR | Management | For | For |
1.3 | ELECT G. MORGAN BROWNE AS A DIRECTOR | Management | For | For |
1.4 | ELECT SANTO J. COSTA AS A DIRECTOR | Management | For | For |
1.5 | ELECT DARYL K. GRANNER, M.D. AS A DIRECTOR | Management | For | For |
1.6 | ELECT JOSEPH KLEIN, III AS A DIRECTOR | Management | For | For |
1.7 | ELECT W.M. LOVENBERG, PH.D. AS A DIRECTOR | Management | For | For |
1.8 | ELECT VIREN MEHTA AS A DIRECTOR | Management | For | For |
1.9 | ELECT DAVID W. NIEMIEC AS A DIRECTOR | Management | For | For |
1.10 | ELECT HERBERT PINEDO, MD, PHD AS A DIRECTOR | Management | For | For |
1.11 | ELECT SIR MARK RICHMOND, PHD AS A DIRECTOR | Management | For | For |
1.12 | ELECT KATHARINE B. STEVENSON AS A DIRECTOR | Management | For | For |
1.13 | ELECT JOHN P. WHITE AS A DIRECTOR | Management | For | For |
2 | PROPOSAL TO AMEND THE OSI PHARMACEUTICALS, INC. SECOND AMENDED AND RESTATED BYLAWS TO PERMIT STOCKHOLDERS UNDER CERTAIN CIRCUMSTANCES TO CALL SPECIAL MEETINGS. | Management | For | For |
3 | PROPOSAL TO RATIFY THE APPOINTMENT OF KPMG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE CORPORATION FOR THE FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: PDL BIOPHARMA, INC. MEETING DATE: 06/14/2006 | ||||
TICKER: PDLI SECURITY ID: 69329Y104 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT KAREN A. DAWES AS A DIRECTOR | Management | For | For |
1.2 | ELECT BRADFORD S. GOODWIN AS A DIRECTOR | Management | For | For |
1.3 | ELECT MARK MCDADE AS A DIRECTOR | Management | For | For |
2 | TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
3 | TO APPROVE ANY ADJOURNMENTS OF THE MEETING TO ANOTHER TIME OR PLACE, IF NECESSARY IN THE JUDGMENT OF THE PROXY HOLDERS, FOR THE PURPOSE OF SOLICITING ADDITIONAL PROXIES IN FAVOR OF ANY OF THE FOREGOING PROPOSALS. | Management | For | Abstain |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: REGENERON PHARMACEUTICALS, INC. MEETING DATE: 06/09/2006 | ||||
TICKER: REGN SECURITY ID: 75886F107 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT CHARLES A. BAKER AS A DIRECTOR | Management | For | For |
1.2 | ELECT MICHAEL S. BROWN, M.D. AS A DIRECTOR | Management | For | For |
1.3 | ELECT ARTHUR F. RYAN AS A DIRECTOR | Management | For | For |
1.4 | ELECT GEORGE L. SING AS A DIRECTOR | Management | For | For |
2 | PROPOSAL TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: RENOVIS, INC. MEETING DATE: 06/05/2006 | ||||
TICKER: RNVS SECURITY ID: 759885106 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT ANTHONY B. EVNIN, PH.D. AS A DIRECTOR | Management | For | For |
1.2 | ELECT JUDITH A. HEMBERGER PHD AS A DIRECTOR | Management | For | For |
2 | RATIFICATION OF THE SELECTION OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR 2006 | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: SALIX PHARMACEUTICALS, LTD. MEETING DATE: 09/30/2005 | ||||
TICKER: SLXP SECURITY ID: 795435106 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | TO APPROVE THE ISSUANCE OF SALIX PHARMACEUTICALS, LTD. COMMON STOCK IN THE MERGER OF METAL ACQUISITION CORP, A WHOLLY OWNED SUBSIDIARY OF SALIX PHARMACEUTICALS, LTD., WITH AND INTO INKINE PHARMACEUTICAL COMPANY, INC. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: SEPRACOR INC. MEETING DATE: 05/18/2006 | ||||
TICKER: SEPR SECURITY ID: 817315104 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT JAMES G. ANDRESS AS A DIRECTOR | Management | For | For |
1.2 | ELECT ROBERT J. CRESCI AS A DIRECTOR | Management | For | For |
1.3 | ELECT JAMES F. MRAZEK AS A DIRECTOR | Management | For | For |
2 | TO APPROVE AN AMENDMENT TO OUR 2000 STOCK INCENTIVE PLAN INCREASING FROM 9,500,000 TO 11,500,000 THE NUMBER OF SHARES OF OUR COMMON STOCK RESERVED FOR ISSUANCE UNDER THE 2000 PLAN. | Management | For | Against |
3 | TO APPROVE AN AMENDMENT TO OUR 1998 EMPLOYEE STOCK PURCHASE PLAN INCREASING FROM 900,000 TO 1,400,000 THE NUMBER OF SHARES OF OUR COMMON STOCK RESERVED FOR ISSUANCE UNDER THE 1998 PURCHASE PLAN. | Management | For | For |
4 | TO RATIFY THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE CURRENT FISCAL YEAR. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: SEROLOGICALS CORPORATION MEETING DATE: 05/10/2006 | ||||
TICKER: SERO SECURITY ID: 817523103 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT DAVID A. DODD AS A DIRECTOR | Management | For | For |
1.2 | ELECT RONALD G. GELBMAN AS A DIRECTOR | Management | For | For |
2 | TO RATIFY THE APPOINTMENT OF INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDED DECEMBER 31, 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: SKYEPHARMA PLC MEETING DATE: 07/18/2005 | ||||
TICKER: -- SECURITY ID: G1145K144 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | RECEIVE AND ADOPT THE ANNUAL REPORT AND ACCOUNTS FOR THE YE 31 DEC 2004 | Management | For | For |
2 | APPROVE THE DIRECTORS REMUNERATION REPORT CONTAINED IN THE ANNUAL REPORT AND ACCOUNTS FOR THE FYE 31 DEC 2004 | Management | For | For |
3 | RE-APPOINT PRICEWATERHOUSECOOPERS LLP AS THE AUDITORS OF THE COMPANY UNTIL THE CONCLUSION OF THE NEXT GENERAL MEETING OF THE COMPANY AND AUTHORIZE THE DIRECTORS TO FIX THEIR REMUNERATION | Management | For | For |
4 | RE-ELECT MR. MICHAEL ASHTON AS A DIRECTOR, WHO RETIRES BY ROTATION IN ACCORDANCE WITH THE ARTICLES OF ASSOCIATION OF THE COMPANY | Management | For | For |
5 | RE-ELECT MR. STEPHEN HARRIS AS A DIRECTOR, WHO RETIRES BY ROTATION IN ACCORDANCE WITH THE ARTICLES OF ASSOCIATION OF THE COMPANY | Management | For | For |
6 | RE-ELECT DR. JERRY KARABELAS AS A DIRECTOR, WHO RETIRES BY ROTATION IN ACCORDANCE WITH THE ARTICLES OF ASSOCIATION OF THE COMPANY | Management | For | For |
7 | RE-ELECT SIR. MICHAEL BEAVIS AS A DIRECTOR, WHO RETIRES IN ACCORDANCE WITH SECTION 293 OF THE COMPANIES ACT 1985 THE ACT | Management | For | For |
8 | RE-ELECT DR. KEITH MANSFORD AS A DIRECTOR, WHO RETIRES IN ACCORDANCE WITH SECTION 293 OF THE ACT | Management | For | For |
9 | APPOINT MR. ALAN BRAY, AS A DIRECTOR IN ACCORDANCE WITH THE ARTICLES OF ASSOCIATION OF THE COMPANY | Management | For | For |
10 | AUTHORIZE THE DIRECTORS, IN SUBSTITUTION FOR ANY EXISTING AUTHORITY AND FOR THE PURPOSE OF SECTION 80 OF THE COMPANIES ACT 1985, TO ALLOT RELEVANT SECURITIES SECTION 80 UP TO AN AGGREGATE NOMINAL AMOUNT OF GBP 20,746,624 1/3 OF THE COMPANY S ISSUED ORDINARY SHARE CAPITAL AS AT 31 DEC 2004 ; AUTHORITY EXPIRES AT THE CONCLUSION OF THE NEXT AGM OF THE COMPANY ; AND THE DIRECTORS MAY ALLOT RELEVANT SECURITIES AFTER THE EXPIRY OF THIS AUTHORITY IN PURSUANCE OF SUCH AN OFFER OR AGREEMENT MADE PRIO... | Management | For | For |
11 | AUTHORIZE THE DIRECTORS, TO ALLOT CASH EQUITY SECURITIES SECTION 89 PURSUANT TO THE GENERAL AUTHORITY CONFERRED ON THEM UNDER SECTION 80 OF THE ACT TO SELL OR MAKE OFFERS OR AGREEMENTS TO SELL EQUITY SECURITIES WHICH IMMEDIATELY BEFORE THE SALE ARE HELD BY THE COMPANY AS TREASURY SHARES SECTION 162A OF THE ACT , DISAPPLYING THE STATUTORY PRE-EMPTION RIGHTS SECTION 89(1) , PROVIDED THAT THIS POWER IS LIMITED TO THE ALLOTMENT OF EQUITY SECURITIES: 1) TO THE ALLOTMENT OF EQUITY SECURITIES, WHE... | Management | For | For |
12 | AUTHORIZE THE COMPANY, TO MAKE MARKET PURCHASES SECTION 163 OF THE ACT OF UP TO GBP 6,223,987 NOMINAL VALUE OF ORDINARY SHARES, AT A MINIMUM PRICE OF 10 PENCE AND UP TO 105% OF THE AVERAGE MIDDLE MARKET QUOTATIONS FOR SUCH SHARES DERIVED FROM THE LONDON STOCK EXCHANGE DAILY OFFICIAL LIST, OVER THE PREVIOUS 5 BUSINESS DAYS; ; AUTHORITY EXPIRES AT THE CONCLUSION OF THE NEXT AGM OF THE COMPANY ; THE COMPANY, BEFORE THE EXPIRY, MAY MAKE A CONTRACT TO PURCHASE ORDINARY SHARES WHICH WILL OR MAY BE... | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: TANOX, INC. MEETING DATE: 06/02/2006 | ||||
TICKER: TNOX SECURITY ID: 87588Q109 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT NANCY T. CHANG AS A DIRECTOR | Management | For | For |
1.2 | ELECT DANONG CHEN AS A DIRECTOR | Management | For | For |
1.3 | ELECT JULIA R. BROWN AS A DIRECTOR | Management | For | For |
1.4 | ELECT GARY E. FRASHIER AS A DIRECTOR | Management | For | For |
2 | TO APPROVE AMENDMENTS TO THE 2000 NON-EMPLOYEE DIRECTORS STOCK OPTION PLAN | Management | For | For |
3 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS INDEPENDENT AUDITORS FOR 2006 | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: TECHNE CORPORATION MEETING DATE: 10/27/2005 | ||||
TICKER: TECH SECURITY ID: 878377100 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | TO SET THE NUMBER OF DIRECTORS AT SIX. | Management | For | For |
2.1 | ELECT THOMAS E. OLAND AS A DIRECTOR | Management | For | For |
2.2 | ELECT ROGER C. LUCAS, PH.D. AS A DIRECTOR | Management | For | For |
2.3 | ELECT HOWARD V. O'CONNELL AS A DIRECTOR | Management | For | For |
2.4 | ELECT G. ARTHUR HERBERT AS A DIRECTOR | Management | For | For |
2.5 | ELECT R.C. STEER, MD, PH.D. AS A DIRECTOR | Management | For | For |
2.6 | ELECT ROBERT V. BAUMGARTNER AS A DIRECTOR | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: TELIK, INC. MEETING DATE: 05/25/2006 | ||||
TICKER: TELK SECURITY ID: 87959M109 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT DR. STEFAN RYSER, PH.D. AS A DIRECTOR | Management | For | For |
1.2 | ELECT MR. ROBERT W. FRICK AS A DIRECTOR | Management | For | For |
1.3 | ELECT DR. MARY ANN GRAY, PHD AS A DIRECTOR | Management | For | For |
2 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
3 | TO APPROVE AN AMENDMENT TO THE COMPANY S 2000 NON-EMPLOYEE DIRECTORS STOCK OPTION PLAN TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK RESERVED FOR FUTURE ISSUANCE BY 300,000 SHARES. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: TERCICA, INC. MEETING DATE: 06/06/2006 | ||||
TICKER: TRCA SECURITY ID: 88078L105 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT ALEXANDER BARKAS, PH.D. AS A DIRECTOR | Management | For | For |
1.2 | ELECT DENNIS HENNER, PH.D. AS A DIRECTOR | Management | For | For |
1.3 | ELECT MARK LESCHLY AS A DIRECTOR | Management | For | For |
2 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS TERCICA S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: TEVA PHARMACEUTICAL INDUSTRIES LIMIT MEETING DATE: 10/27/2005 | ||||
TICKER: TEVA SECURITY ID: 881624209 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | TO APPROVE THE ISSUANCE OF ORDINARY SHARES OF TEVA, PURSUANT TO THE AGREEMENT AND PLAN OF MERGER, DATED JULY 25, 2005, BY AND AMONG IVAX CORPORATION, TEVA AND TWO WHOLLY OWNED SUBSIDIARIES OF TEVA, IVORY ACQUISITION SUB, INC. AND IVORY ACQUISITION SUB II, INC. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: THE MEDICINES COMPANY MEETING DATE: 05/25/2006 | ||||
TICKER: MDCO SECURITY ID: 584688105 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT ARMIN M. KESSLER AS A DIRECTOR | Management | For | For |
1.2 | ELECT ROBERT G. SAVAGE AS A DIRECTOR | Management | For | For |
1.3 | ELECT MELVIN K. SPIGELMAN AS A DIRECTOR | Management | For | For |
2 | RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
3 | APPROVE THE AMENDMENT TO THE COMPANY S 2004 STOCK INCENTIVE PLAN TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THE PLAN FROM 4,400,000 TO 8,800,000. | Management | For | Against |
4 | APPROVE THE AMENDMENT TO THE COMPANY S 2000 EMPLOYEE STOCK PURCHASE PLAN TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THE PLAN FROM 255,500 TO 505,500. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: THERAVANCE, INC. MEETING DATE: 04/26/2006 | ||||
TICKER: THRX SECURITY ID: 88338T104 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT P. ROY VAGELOS, M.D. AS A DIRECTOR | Management | For | For |
1.2 | ELECT RICK E. WINNINGHAM AS A DIRECTOR | Management | For | For |
1.3 | ELECT JULIAN C. BAKER AS A DIRECTOR | Management | For | For |
1.4 | ELECT JEFFREY M. DRAZAN AS A DIRECTOR | Management | For | For |
1.5 | ELECT ROBERT V. GUNDERSON, JR AS A DIRECTOR | Management | For | For |
1.6 | ELECT ARNOLD J. LEVINE, PH.D. AS A DIRECTOR | Management | For | For |
1.7 | ELECT RONN C. LOEWENTHAL AS A DIRECTOR | Management | For | For |
1.8 | ELECT EVE E. SLATER, M.D. AS A DIRECTOR | Management | For | For |
1.9 | ELECT WILLIAM H. WALTRIP AS A DIRECTOR | Management | For | For |
1.10 | ELECT G.M. WHITESIDES, PH.D. AS A DIRECTOR | Management | For | For |
1.11 | ELECT WILLIAM D. YOUNG AS A DIRECTOR | Management | For | For |
2 | TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THERAVANCE, INC. FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: THRESHOLD PHARMACEUTICALS, INC. MEETING DATE: 05/25/2006 | ||||
TICKER: THLD SECURITY ID: 885807107 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT MR. WILLIAM A. HALTER AS A DIRECTOR | Management | For | For |
1.2 | ELECT DR. WILFRED E. JAEGER AS A DIRECTOR | Management | For | For |
2 | TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: VERTEX PHARMACEUTICALS INCORPORATED MEETING DATE: 05/11/2006 | ||||
TICKER: VRTX SECURITY ID: 92532F100 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT ERIC K. BRANDT AS A DIRECTOR | Management | For | For |
1.2 | ELECT BRUCE I. SACHS AS A DIRECTOR | Management | For | For |
1.3 | ELECT EVE E. SLATER AS A DIRECTOR | Management | For | For |
2 | APPROVAL OF THE VERTEX PHARMACEUTICALS INCORPORATED 2006 STOCK AND OPTION PLAN. | Management | For | Against |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: VIACELL, INC. MEETING DATE: 05/19/2006 | ||||
TICKER: VIAC SECURITY ID: 92554J105 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT PAUL BLAKE AS A DIRECTOR | Management | For | For |
1.2 | ELECT PAUL HASTINGS AS A DIRECTOR | Management | For | For |
1.3 | ELECT JAN VAN HEEK AS A DIRECTOR | Management | For | For |
2 | RATIFICATION OF THE SELECTION OF PRICEWATERHOUSECOOPERS, LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: VION PHARMACEUTICALS, INC. MEETING DATE: 06/27/2006 | ||||
TICKER: VION SECURITY ID: 927624106 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT WILLIAM R. MILLER AS A DIRECTOR | Management | For | For |
1.2 | ELECT GEORGE BICKERSTAFF AS A DIRECTOR | Management | For | For |
1.3 | ELECT STEPHEN K. CARTER, M.D. AS A DIRECTOR | Management | For | For |
1.4 | ELECT ALAN KESSMAN AS A DIRECTOR | Management | For | For |
1.5 | ELECT ALAN C. SARTORELLI, PHD AS A DIRECTOR | Management | For | For |
1.6 | ELECT IAN WILLIAMS AS A DIRECTOR | Management | For | For |
1.7 | ELECT GARY K. WILLIS AS A DIRECTOR | Management | For | For |
2 | RATIFICATION OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT AUDITORS. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: XENOPORT, INC. MEETING DATE: 05/02/2006 | ||||
TICKER: XNPT SECURITY ID: 98411C100 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT BRYAN E. ROBERTS, PH.D. AS A DIRECTOR | Management | For | For |
1.2 | ELECT G.D. TOLLEFSON, MD, PHD AS A DIRECTOR | Management | For | For |
2 | TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
ISSUER NAME: ZYMOGENETICS, INC. MEETING DATE: 06/15/2006 | ||||
TICKER: ZGEN SECURITY ID: 98985T109 | ||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | ELECT JUDITH A HEMBERGER PHD* AS A DIRECTOR | Management | For | For |
1.2 | ELECT DAVID I. HIRSH, PH.D.** AS A DIRECTOR | Management | For | For |
1.3 | ELECT DAVID H. MACCALLUM** AS A DIRECTOR | Management | For | For |
1.4 | ELECT KURT ANKER NIELSEN** AS A DIRECTOR | Management | For | For |
2 | APPROVAL OF 2001 STOCK INCENTIVE PLAN | Management | For | For |
3 | APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP | Management | For | For |
Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. |
POWER OF ATTORNEY
I, the undersigned Treasurer of the following investment companies:
Colchester Street Trust Fidelity Aberdeen Street Trust Fidelity Advisor Series I Fidelity Advisor Series II Fidelity Advisor Series IV Fidelity Advisor Series VIII Fidelity California Municipal Trust Fidelity Capital Trust Fidelity Central Investment Portfolios LLC Fidelity Charles Street Trust Fidelity Commonwealth Trust Fidelity Concord Street Trust Fidelity Contrafund Fidelity Court Street Trust Fidelity Court Street Trust II Fidelity Destiny Portfolios Fidelity Devonshire Trust | Fidelity Financial Trust Fidelity Hastings Street Trust Fidelity Hereford Street Trust Fidelity Investment Trust Fidelity Magellan Fund Fidelity Massachusetts Municipal Trust Fidelity Money Market Trust Fidelity School Street Trust Fidelity Union Street Trust Fidelity Union Street Trust II Newbury Street Trust Variable Insurance Products Fund Variable Insurance Products Fund II Variable Insurance Products Fund III Variable Insurance Products Fund IV |
plus any other investment company for which Fidelity Management & Research Company or an affiliate acts as investment adviser and for which the undersigned individual serves as Treasurer (collectively, the "Funds"), hereby constitute and appoint Nicholas Steck and Claire Walpole my true and lawful attorneys-in-fact, each of them singly, with full power of substitution, and with full power to sign for me and in my name in the appropriate capacities, all Reports of the Proxy Voting Records of the Funds on Form N-PX under the Investment Company Act of 1940, as amended (the "Act"), or any successor thereto, and any supplements or other instruments in connection therewith, and generally to do all such things in my name and behalf in connection therewith as said attorneys-in-fact deem necessary or appropriate to cause such Form to be completed and filed in accordance with the Act and all related requirements of the Securities and Exchange Commission. I hereby ratify and confirm all that said attorneys-in-fact or their substitute may do or cause to be done by virtue hereof. This power of attorney is effective for all documents filed on or after August 1, 2006.
WITNESS my hand on this 31st of July 2006.
/s/ Christine Reynolds
Christine Reynolds
Treasurer